baber/WOPTO huggingface dataset:
Patent AU-667924-B2 (AU)
Title: Heteroacetic acid derivatives
Inventor: YOKOYAMA NAOKATA
IPC: C07C233/56
Filed: 1993-07-20
Granted: 1996-04-18
Abstract: Disclosed are compounds of formula <CHEM>  wherein     R is hydrogen, hydroxy, esterified hydroxy or etherified hydroxy;     R1 is hydrogen, halogen, trifluoromethyl or lower alkyl;     R2 is hydrogen, halogen, trifluoromethyl or lower alkyl; R3 is halogen, trifluoromethyl, lower alkyl, aryl, aryl-lower alkyl, cycloalkyl or cycloalkyl-lower alkyl; or     R3 is the radical <CHEM> wherein R8 is hydrogen, lower alkyl, aryl, cycloalkyl, aryl-lower alkyl or cycloalkyl-lower alkyl; R9 is hydroxy or acyloxy; R10 represents hydrogen or lower alkyl; or R9 and R10 together represent oxo;     R4 is hydrogen, halogen, trifluoromethyl or lower alkyl;     X is -NR7;     W is O or S;     R5 and R6 together represent oxo;     R7 represents hydrogen or lower alkyl; Z represents carboxyl, carboxyl derivatized as a pharmaceutically acceptable ester or as a pharmaceutically acceptable amide; and pharmaceutically acceptable salts thereof; which are useful as hypocholesteremic agents.
Patent AU-579970-B2 (AU)
Title: Self-adhesive plaster containing medication
Inventor: NICK ERICH
IPC: A61M37/00
Filed: 1985-05-28
Granted: 1988-12-15
Abstract: A self-adhesive medicinal plaster comprises a plurality of adhesive elements spaced from each other on a surface of a carrier web and a plurality of active ingredient elements, containing a medication, spaced from each other and from the active ingredient elements on the surface of the carrier web whereby the medicinal active ingredient composition is isolated from the adhesive composition.
Patent AU-733535-B2 (AU)
Title: Human applications of controlled stress
Inventor: FIELDING STUART
IPC: A61H7/00
Filed: 1997-09-12
Granted: 2001-05-17
Abstract: An effect analogous to a tail-pinch effect is evoked in humans by apparatus for applying variable localized pressure to the spine. Control of the pressure can be accomplished manually, by remote control and/or automatically. By selectively applying pressure a number of changes can be evoked in the human including, for example, causing an increase in appetite, a change in sexual behavior, increased blood flow to brain, and/or an increase of neurotransmitters, including dopamine, serotonin and norepinephrine. The effect is useful in treating Parkinson's disease, depressive disorders, stroke and other conditions.
Patent AU-699669-B2 (AU)
Title: Method for producing newspapers and magazines
Inventor: HONEGGER WERNER
IPC: G06Q10/10
Filed: 1996-01-23
Granted: 1998-12-10
Abstract: PCT No. PCT/CH96/00031 Sec. 371 Date Sep. 11, 1997 Sec. 102(e) Date Sep. 11, 1997 PCT Filed Jan. 23, 1996 PCT Pub. No. WO96/23665 PCT Pub. Date Aug. 8, 1996In a method for producing a predetermined sequence of printed products with varying contents and varying numbers of pages, the pages of a printed product of the sequence are printed onto both sides of a quasi-endless paper web [P] in the form of at least one row of juxtaposed printed pages. The pages of the next printed product in the sequence are then printed in the same manner. The paper web is folded perpendicular to its length in alternating directions between the pages to be printed, or the printed pages, before or after printing. The web is then separated or brought into an easily separable condition along lines perpendicular to its length between groups of printed pages forming successive printed products. A sequence of Leporello-shaped printed products [5] is produced which can be further processed into differently shaped products. By mixing the data specific to the type of printed product to be produced with data specific to individual specimens of the product, the contents of the products of the sequence can be individualized to choice.
Patent AU-664300-B2 (AU)
Title: Fastening element for the adjustable fastening of a sheet to a frame element, and a wall element
Inventor: HAAB KARL
IPC: E05D15/06
Filed: 1993-08-04
Granted: 1995-11-09
Abstract: For the adjustable fastening of a glass panel in a receiving groove of an upper frame strip, the former has, in the vicinity of the two ends of the upper edge region, circular holes through which fastening elements are inserted. Each fastening element consists of a tie part (5) with an outer surface (13) which is approximately cylindrically symmetrical about an adjusting axis (12) and which is meshed with an inner surface (14) of a holding part (6) slipped onto the tie part (5). The tie part (5) engages with axially projecting tie pins (8) into continuous tie grooves made laterally in the receiving groove. The edge of the hole in the glass panel touches the holding part (6) on an outer contact surface (7) which is rotationally symmetrical about an eccentric axis (15) parallel to the adjusting axis (12) and spaced from the latter by the amount of an eccentricity ( DELTA ). The holding part (6) can be drawn off from the tie part (5) and slipped on again, rotated through a multiple of an increment ( alpha ) about the adjusting axis (12), with the result that the vertical position of the contact surface (7) in relation to the tie part (5) and therefore the position of the glass panel in relation to the frame strip changes. <IMAGE>
Patent AU-773007-B2 (AU)
Title: Composite materials for membrane reactors
Inventor: KLEEFISCH MARK S
IPC: C04B38/00
Filed: 2000-04-20
Granted: 2004-05-13
Abstract: Composite materials of the invention, which include a gas-tight ceramic, a porous metallic support, and an interfacial zone therebetween eliminate the need for mechanical seals between two such dissimilar materials. Oxygen ion-conducting dense ceramic membranes are formed on a porous metallic alloy to provide an interfacial zone identifiable by a gradient of composition in at least one metallic element across the interfacial zone between the dense ceramic membrane and the porous support. Processes using composite materials in accordance with the invention are, for example, used for production of synthesis gas comprising carbon monoxide and molecular hydrogen, whereby the synthesis gas is, advantageously, free of deleterious and/or inert gaseous diluents such as nitrogen.
Patent AU-725179-B2 (AU)
Title: Apparatus for controlling gas temperature in compressors
Inventor: CONEY MICHAEL WILLOUGHBY ESSEX
IPC: F04B39/06
Filed: 1997-10-14
Granted: 2000-10-05
Abstract: An apparatus is provided for controlling gas temperature during compression or expansion. The apparatus comprises a chamber for containing gas, a piston for changing the volume of gas in the chamber, a plurality of atomisers for spraying liquid into the chamber and means for delivering liquid to the atomisers. Each atomiser comprises a spray aperture and means defining a flow path for imparting rotary motion to the flow of liquid about the axis of the aperture so that on leaving the aperture the liquid divides into a conical spray. Spray apertures are positioned adjacent one another and the axes of adjacent spray apertures are oriented such that their respective sprays intersect at a position proximate at least one of the respective adjacent spray apertures.
Patent AU-781131-B2 (AU)
Title: System for electrochemical quantitative analysis of analytes within a solid phase
Inventor: LU FANG
IPC: G01N33/558
Filed: 2000-05-05
Granted: 2005-05-05
Abstract: System, method, and test strip for solid phase, electrochemical, quantitative analysis of analytes contained in biological fluid samples. Preliminary to analysis, a test sample solution can be applied to a sample collection pad associated with the solid phase test environment of the test strip. The test sample solution and a test kit reagent are thereby initially contacted, under assay conditions, within this solid phase test environment, and caused to migrate along a fluid pathway therein. Irrespective of the assay format (competitive assay, sandwich assay, etc.), a test kit reagent (e.g. labeled substance) and the analyte of interest (e.g. proteins, hormones or enzymes, small molecules, polysaccharides, antibodies, nucleic acids, drugs, toxins, viruses or virus particles, portions of a cell wall and other compounds which have specific or characteristic markers that permit their identification), either interact with one another to form a complex, or, alternatively, compete with one another for interaction with another test kit reagent, resulting in the concentration of an indicator substance within a delimited area of the solid phase. Thereafter, the delimited area of the test strip is subjected to electrochemical analysis and the results determined by monitoring an electrochemical transition in the form of an indicator, or derivative of the indicator (e.g. indicator species), by potentiostatic or potentiometric quantitative analysis (e.g. anodic stripping voltammetry). This electrochemical transition of the indicator has a characteristic electrical fingerprint that can be measured and which, when compared to a standard, can be correlated with the concentration of the analyte in the sample. This method is suitable for the determination/monitoring of therapeutic range of drugs (anti-convulsants drugs), determination of critical and potentially dangerous levels of endogenous materials which are indicative of disease states (prostate cancer), and numerous other applications presently requiring elaborate and time-consuming clinical laboratory analysis.
Patent AU-751162-B2 (AU)
Title: Medical puncturing device
Inventor: LARSEN BJORN GULLAK
IPC: A61M5/32
Filed: 1999-07-13
Granted: 2002-08-08
Abstract: The invention relates to a medical puncturing device comprising a rigid needle being at one end adapted for facilitating the puncturing and comprising at the opposite end a hub, the hub comprising a handle part and a shield part being pivotable in relation to the handle part and further comprising locking means on the shield part and the handle part, the locking means being adapted to interlock the shield and the handle part in a pivoted position of the shield part where the rigid needle is covered by this.
Patent AU-674547-B2 (AU)
Title: Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
Inventor: BUIZER NICOLAAS
IPC: C07D319/16
Filed: 1993-12-17
Granted: 1997-01-02
Abstract: The invention relates to substantially pure hetero-bicyclic alcohol enantiomers of the formula I, III, and IV <CHEM>       wherein X is O, S, NH, N-(C1-C4)alkyl or CH2; Y1, Y2 and Y3 are each independently hydrogen or substituents selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4-haloalkyl, nitro and cyano;   the NO2 substituent is attached to the bicyclic ring system in   the 5- or 7-position; and   the C*-atom has either the R configuration.   The invention also relates to the use of said enantiomers for the preparation of a pharmacologically active piperazine derivative.
Patent AU-623772-B2 (AU)
Title: Method of exterminating rodents and other vertebrate pests
Inventor: DELUCA HECTOR F
IPC: A01N49/00
Filed: 1990-05-17
Granted: 1992-05-21
Abstract: A method for controlling vertebrate pest populations such as rodents, starlings and blackbirds which comprises making available to such pest populations a vitamin D compound in a high calcium bait diet.
Patent AU-708538-B2 (AU)
Title: Sucrose metabolism mutants
Inventor: MATTES RALF
IPC: C12N15/00
Filed: 1996-06-27
Granted: 1999-08-05
Abstract: Cells contg. at least one DNA sequence encoding a protein with sucrose isomerase activity, and having reduced ability to metabolise sucrose, are new. Also new is the use of a nucleic acid, or fragments, encoding a sucrose metabolising enzyme, for the prodn. of a mutagenic vector.
Patent AU-633923-B2 (AU)
Title: Substituted aminoalkylbenzene derivatives
IPC: C07C225/10
Filed: 1990-06-04
Granted: 1993-02-11
Abstract: The compounds of the general formula 
<IMAGE>
 in which R<1> and R<2> each denote hydrogen, lower alkyl or lower alkenyl or together denote straight-chain alkylene having 2 to 4 carbon atoms, R<3> denotes hydrogen, halogen or lower alkyl, Q denotes alkylene having 2 to 11 carbon atoms and at least 2 carbon atoms between the two free valencies or alkenylene having 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies and Y and Y' each denote a direct bond or the group -CH2-, -CH2CH2-, -CH=CH- or -C IDENTICAL C-, the group R<1>R<2>N-Q-CH2- is bonded to the 3- or 4-position of the ring designated A, and the symbol R denotes that the ring is unsubstituted or substituted by halogen, trifluoromethyl, cyano, nitro, lower alkyl or lower alkoxy,
 and their pharmaceutically acceptable acid addition salts have useful pharmacological properties. In particular, they have a pronounced antifungal action and exhibit synergistic effects in combination with known antifungal substances which inhibit sterol biosynthesis, such as ketoconazole and terbinafine. The compounds of the formula I can therefore be used as medicaments, in particular for the control or prevention of topical or systemic infections which are caused by pathogenic fungi.
Patent AU-721914-B2 (AU)
Title: Flow-through photo-chemical reactor
Inventor: COOKE JEFFREY
IPC: B01J19/24
Filed: 1996-05-09
Granted: 2000-07-20
Abstract: A flow-through photochemical reactor includes a reactor body, that circumscribes a longitudinally extending channel having a generally annular cross section. This channel accommodates fluids passing between an inner wall of the reactor body and an outer wall of a photon-transmitting tube that is housed internally thereof. In addition, the reactor includes mechanically static, fluid-dynamic elements for passively inducing substantial turbulent flow within a fluid as it passes through the channel. This arrangement substantially increases the uniformity of the fluid's exposure to photons radiating from a source within the tube into the fluid an it is conducted through the channel.
Patent AU-628606-B2 (AU)
Title: Filters
Inventor: WAHL HANS-PETER
IPC: B01D39/20
Filed: 1990-07-20
Granted: 1992-09-17
Abstract: A filter for use in the filtration of molten metals comprises a ceramic foam (1) having a gasket (2) made from fibrous material surrounding its peripheral surface and a metallic foil (3), such as aluminium foil, fixed to the gasket (2), for example by means of an adhesive, around the outer peripheral surface of the gasket (2).
Patent AU-633119-B2 (AU)
Title: Improved asymmetric catalytic hydrogenation of alpha-arylpropenoic acids
IPC: C07F15/00
Filed: 1990-06-22
Granted: 1993-01-21
Abstract: Process for producing an  alpha -arylpropionic acid comprising catalytically asymmetrically hydrogenating the dehydration product of an acid-treated electrochemically carboxylated  alpha -arylketone corresponding to said  alpha -arylpropionic acid wherein the hydrogenation is conducted using an asymmetric hydrogenation ruthenium catalyst at a temperature less than 30 DEG C optionally in the presence of a base.
Patent AU-589984-B2 (AU)
Title: An apparatus for compensating a movement of a picture of television signal
Inventor: MATSUMOTO KUNIO
IPC: H04N5/14
Filed: 1986-07-25
Granted: 1989-10-26
Abstract: image movement correction is provided for example in a field conversion television system by deriving simultaneously two fields of a selected number of lines from an original single field and vertically shifting one of the derived fields by 0.5 lines. A movement vector is determined (5) for each field and movement correction is performed based on a current field and a preceding field, in the case of a moving object in the image. If no moving object is present, linear approximation is employed to correct for motion caused by the field number conversion. Two memory systems (51 to 54 and 55 to 58) are provided for the two simultaneous fields and also selectively to obtain specific horizontal lines of the current and preceding fields, relative to both simultaneously derived fields. Ultimate selection of a field for display is based upon the detected movement vector.
Patent AU-747479-B2 (AU)
Title: The 74 kilodalton outer membrane protein from (moraxella catarrhalis)
Inventor: CHEN DEXIANG
IPC: A61K39/00
Filed: 1998-01-29
Granted: 2002-05-16
Abstract: A protein from M. catarrhalis, designated the 74 kD protein, is isolated and purified. The 74 kD protein has an amino-terminal amino acid sequence which is conserved among various strains of M. catarrhalis. The protein has a molecular weight of approximately 74.9 kD as measured on a 10% SDS-PAGE gel, while its molecular weight as measured by mass spectrometry is approximately 74 kD. The 74 kD protein is used to prepare a vaccine composition which elicits a protective immune response in a mammalian host, to protect the host against disease caused by M. catarrhalis.
Patent AU-676722-B2 (AU)
Title: Methods and compositions for inhibition of angiogenesis
Inventor: AMATO ROBERT D
IPC: A61K31/404
Filed: 1994-02-24
Granted: 1997-03-20
Abstract: Thalidomide for treating solid and blood-borne tumours, wherein said tumour is a breast cancer, leukaemia, neoplastic disease of the bone marrow, Kaposi's sarcoma, hemangioma, rhabdomyosarcoma, Ewing's sarcoma, neuroblastoma, osteosarcoma, acoustic neuroma, neurofibroma, trachoma, or pyogenic granuloma;and for treating ocular neovascular disease, macular degeneration, proliferative vitreoretinopathy, retrolental fibroplasia, psoriasis, Crohn's disease, diabetic retinopathy, Osler-Weber-Rendu disease, hereditary hemorrhagic telangienctasia or osteoarthritis.
Patent AU-706701-B2 (AU)
Title: Intelligent memory management system and method
Inventor: LAZARUS DAVID BERYL
IPC: H04H20/00
Filed: 1996-06-06
Granted: 1999-06-24
Abstract: A television electronic program guide intelligent memory management system and method automatically deletes the least valuable stored program information at that moment as free memory space is needed by the system. In advance of a program schedule update, the system executes a two-level memory "housekeeping" operation in which the system first scans the memory to identify obsolete schedule information. If, after this sweep, there is insufficient memory available for the next update, the system performs a second-level memory "triage" operation wherein schedule information is automatically prioritized in accordance with pre-defined rules for assessing the current value of the information to each viewer based on program air time, channel and other variables relating to program utility. The system then deletes schedule information in ascending order of value, starting with the least valuable information, and continues until enough space is available in memory to store the schedule update.
Patent AU-737720-B2 (AU)
Title: Formulation of stabilized cationic transfection agent(s)/nucleic acid particles
Inventor: CROUZET JOEL
IPC: A61K47/48
Filed: 1998-02-06
Granted: 2001-08-30
Abstract: The invention concerns a composition containing stabilised particles of cationic transfection agent(s)/nucleic acid complexes characterised in that it includes besides said transfection agent and nucleic acid at least a non-ionic surfactant in sufficient amount for preventing the aggregation of the particles in course of time. In a preferred embodiment, the surfactant is a polyoxyalkylene or a derivative thereof.
Patent AU-667774-B2 (AU)
Title: Articles with intermittently deposited particulate material in a substrate
Inventor: PIEPER CHRISTOPHER MARTIN
IPC: A61F13/15
Filed: 1994-05-10
Granted: 1996-04-04
Abstract: An absorbent article is described which comprises a substantially integral fibrous layer of hydrophilic fibers; and a quantity of superabsorbent particles integrally mixed among said fibers in a non-layered configuration, and arranged with weight percentages of said superabsorbent particles (with respect to a total weight of superabsorbent) nonuniformly distributed along a length dimension of said article with selected length-wise, superabsorbent-containing regions of said fibrous layer having higher percentages of superabsorbent than other length-wise, superabsorbent-containing regions. <IMAGE>
Patent AU-638753-B2 (AU)
Title: Oral compositions comprising a mixture of stannous salts and zinc salts as anti-plaque active system
IPC: A61K8/24
Filed: 1990-10-04
Granted: 1993-07-08
Abstract: Oral compositions such as dentifrices with an improved anti-plaque efficacy are obtained by inclusion therein of a mixture of a stannous salt such as stannousfluoride or stannouspyrophosphate and a zinc salt such as zinc citrate.
Patent AU-729060-B2 (AU)
Title: Isolated nucleic acid molecules encoding SSX family members and uses thereof
Inventor: GURE ALI O
IPC: C07K14/47
Filed: 1998-02-25
Granted: 2001-01-25
Abstract: The invention relates to members of the SSX family of genes, as well as their uses.
Patent AU-583165-B2 (AU)
Title: Chewing gum compositions
Inventor: PATEL MANSUKH M
IPC: A23L27/30
Filed: 1986-10-15
Granted: 1989-04-20
Abstract: Low moisture chewing gum compositions and methods of preparation using carbohydrate syrup-plasticizer compositions to improve flexibility and shelf life characteristics are disclosed. The syrup comprises carbohydrate solids and water, with less than 30% of the solids having a degree of polymerization (DP) of 1 and more than 20% solids with a DP of 4 or greater. The ratio of carbohydrate solids to plasticizing agent in the composition is between 0.5:1 and 100:1 and the total water content of composition is less than 20%. The syrup-plasticizer composition is prepared by providing a carbohydrate syrup or combined syrups with the proper carbohydrate solids distribution, combining a plasticizer such as glycerine or propylene glycol and evaporating water from the combined syrup plasticizer composition. Chewing gum made using the evaporated syrup composition includes about 5% to about 75% gum base, about 5% to about 75% of a sweet bulking agent, about 5% to about 75% of the evaporated syrup composition and optional ingredients used in conventional chewing gums but less than 2% moisture.
Patent AU-584270-B2 (AU)
Title: Novel derivatives of erythromycylamine
Inventor: BONJOUKLIAN ROSANNE
IPC: C07H17/08
Filed: 1987-02-02
Granted: 1989-05-18
Abstract: New 9-N-substituted derivatives of erythromycylamine, having the nucleus <CHEM> with superior oral activity against Gram-positive pathogens, are provided.
Patent AU-679088-B2 (AU)
Title: Apparatus for filtering liquids containing particles
Inventor: FRYKHULT SIRI VIKTORIA
IPC: B01D33/11
Filed: 1994-07-04
Granted: 1997-06-19
Abstract: PCT No. PCT/SE94/00660 Sec. 371 Date Dec. 12, 1995 Sec. 102(e) Date Dec. 12, 1995 PCT Filed Jul. 4, 1994 PCT Pub. No. WO95/01825 PCT Pub. Date Jan. 19, 1995An apparatus for filtering liquids, such as fiber suspensions or polluted water, includes a hollow rotating filter body adapted to receive the liquid to be filtered within the body. A plurality of guide members are attached to the filter body and distributed around the latter to receive cloudy filtrate penetrating the filter body at the descending side. A basin is arranged at the descending side of the filter body to collect cloudy filtrate poured from the guide members. As a result, the cloudy filtrate is prevented from mixing with the clear filtrate.